We found a high rate of metabolic syndrome in subjects who had a lower β-carotene status (<0.8 μM), especially those who suffered from a low-grade inflammatory status (hs-CRP ≥ 1.0 mg/L); on the contrary, the proportion of those with metabolic syndrome was significantly lower for subjects who had a better β-carotene status (≥0.8 μM) (Figure 3). This evidence concerns the gene CRP and metabolic syndrome.